Ryan Specialty Group (RYAN) Q3 2024 earnings summary

Executive summary

• Total revenue grew 20.5% year-over-year to $605 million, driven by 11.8% organic growth and significant M&A contributions.

• Net income increased 82.4% to $28.6 million, with net income margin improving to 4.7%.

• Adjusted EBITDA/EBITDAC rose 29.4% to $190.3 million, with margin expanding to 31.5%.

• Adjusted diluted EPS increased 28% to $0.41 per share.

• Five acquisitions closed through early October, and a leadership transition to a new CEO was completed.

Financial highlights

• Net commissions and fees grew 20.7% year-over-year to $588.1 million; fiduciary investment income rose 13.5%.

• Operating income for Q3 2024 was $81.5 million, up 16.7% from Q3 2023.

• Compensation and benefits expense ratio was 65.0%, and general and administrative expense ratio was 14.7%.

• Adjusted EBITDAC margin improved to 31.5%, up from 29.3% a year ago.

• Cash and cash equivalents at quarter-end were $235.2 million; outstanding debt principal was $2.7 billion.

Outlook and guidance

• Full-year 2024 organic revenue growth guidance remains 13.0%-14.0%.

• Full-year adjusted EBITDA/EBITDAC margin guidance is 32.0%-32.5%.

• ACCELERATE 2025 program is on track to deliver $60 million in annual savings by 2025.

• Optimism for Q4 performance, with strong start and no material change to seasonality.

• Sufficient liquidity and access to capital are expected to support ongoing operations and strategic initiatives.